Question follow-through · 18848
Clinical Trials
To ask the Secretary of State for Health and Social Care, what steps the Department is taking with the devolved administrations to increase the number of patients able to participate in commercial clinical trials across the UK.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 14 Jul 2026
- Target answer date
- 16 Jul 2026
- Answer
- 25 Aug 2026 · 42 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- NHS: Vacancies · 15 Jul 2026
- Brain Cancer: Health Services · 16 Jul 2026
- Brain Cancer: Health Services · 16 Jul 2026
- Cancer: Health Services · 16 Jul 2026
- Cancer: Health Services · 16 Jul 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
14 Jul 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps the Department is taking with the devolved administrations to increase the number of patients able to participate in commercial clinical trials across the UK.
16 Jul 2026
Target answer date
Date supplied by the official written-questions record.
25 Aug 2026
Answer published
The Government is committed to ensuring that all patients across the UK have access to cutting-edge clinical trials and innovative, lifesaving treatments, and we are working with the devolved administrations, delivery partners across the health system, an...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
NHS: Vacancies
15 Jul 2026 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the devolved administrations on developing a coordinated UK approach to addressing shortages in the NHS workforce in key specialties.
Brain Cancer: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, what formal mechanisms are in place to ensure that the views of patients, families and brain cancer patient advocacy organisations are reflected in the work of the National Clinical Lead for Rare C
Brain Cancer: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, by what date liquid biopsy technologies will be routinely available for brain tumour patients across the NHS; how many additional patients are expected to gain access to targeted or repurposed trea
Cancer: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, which recommendations relating to the cancer workforce from previous workforce reviews, task and finish groups, and National Cancer Board workstreams remain outstanding; what assessment has been ma
Cancer: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether the (a) National Clinical Lead for Rare Cancers and (b) Rare Cancer Specialty Lead have been appointed; if so, on what date, and against which National Cancer Plan commitments they will be
Brain Cancer: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether his department will consider the appointment of a specific National Clinical Lead for Brain Cancers.
National Cancer Board
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, what key performance indicators and outcome measures will be used to assess the effectiveness of the National Cancer Board; who will be responsible for overseeing delivery of those outcomes; where
Cancer: Health Services
16 Jul 2026 · To ask the Secretary of State for Health and Social Care, what measurable improvements in (a) workforce capacity, (b) research activity, (c) clinical trial access, (d) speed of diagnosis and (e) patient outcomes are expected as a result of the work of the